Published in Kidney Int on October 08, 2008
Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ (2011) 1.30
Iron supplementation to treat anemia in patients with chronic kidney disease. Nat Rev Nephrol (2010) 1.12
Different peptic ulcer bleeding risk in chronic kidney disease and end-stage renal disease patients receiving different dialysis. Dig Dis Sci (2013) 1.06
Review of Helicobacter pylori infection and chronic renal failure. Ther Apher Dial (2010) 1.03
Peptic ulcer disease risk in chronic kidney disease: ten-year incidence, ulcer location, and ulcerogenic effect of medications. PLoS One (2014) 0.84
Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patients. Clin Exp Nephrol (2010) 0.83
Upper gastrointestinal bleeding in patients with CKD. Clin J Am Soc Nephrol (2014) 0.82
A comparison between standard triple therapy and sequential therapy on eradication of Helicobacter pylori in uremic patients: A randomized clinical trial. Adv Biomed Res (2014) 0.78
Helicobacter pylori Infection in Dialysis Patients: A Meta-Analysis. Gastroenterol Res Pract (2013) 0.77
Comparison of azithromycin and clarithromycin triple therapy regimens for helicobacter pylori eradication in hemodialysis patients. Nephrourol Mon (2012) 0.77
Association between Helicobacter pylori and end-stage renal disease: A meta-analysis. World J Gastroenterol (2017) 0.76
A Comparison between Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Eradication in Patients with Uremia: A Randomized Clinical Trial. Middle East J Dig Dis (2016) 0.75
Helicobacter pylori infection and hypertension in end-stage renal disease. Kidney Int (2009) 0.75
Proton-pump inhibitors for prevention of upper gastrointestinal bleeding in patients undergoing dialysis. World J Gastroenterol (2015) 0.75
Relationship between ghrelin, Helicobacter pylori and gastric mucosal atrophy in hemodialysis patients. World J Gastroenterol (2016) 0.75
Factors aside from Helicobacter pylori play an important role in the occurrence of peptic ulcer in dialysis patients. Kidney Int (2009) 0.75
Association between early Helicobacter pylori eradication and a lower risk of recurrent complicated peptic ulcers in end-stage renal disease patients. Medicine (Baltimore) (2015) 0.75
Comparison of half-dose and full-dose triple therapy regimens for Helicobacter pylori eradication in patients with end-stage renal disease. Gastroenterol Hepatol Bed Bench (2014) 0.75
Helicobacter pylori: Effect of coexisting diseases and update on treatment regimens. World J Gastrointest Pharmacol Ther (2015) 0.75
Helicobacter pylori status and esophagogastroduodenal mucosal lesions in patients with end-stage renal failure on maintenance hemodialysis. J Gastroenterol (2010) 0.75
Helicobacter pylori infection and the development of gastric cancer. N Engl J Med (2001) 17.13
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int (2007) 6.34
Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med (2001) 3.68
Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology (1996) 2.67
Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology (2002) 2.32
Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet (1998) 2.15
The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol (2005) 1.49
Brief report: evaluation of the upper gastrointestinal tract in uraemic patients undergoing haemodialysis. Nephrol Dial Transplant (1996) 1.47
Reversal of iron deficiency anemia after Helicobacter pylori eradication in patients with asymptomatic gastritis. Ann Intern Med (1999) 1.38
Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients. Transplant Proc (2007) 1.11
Gastroduodenal mucosa in uraemia: endoscopic and histological correlation and prevalence of helicobacter-like organisms. Gut (1990) 1.10
Antibiotic treatment for low-grade gastric MALT lymphoma. Lancet (1994) 1.07
Peptic ulcer and gastritis in uraemia, with particular reference to the effect of Helicobacter pylori infection. J Gastroenterol Hepatol (1999) 1.05
Investigation of upper gastrointestinal hemorrhage in chronic renal failure. J Clin Gastroenterol (1996) 1.04
Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings. Eur J Intern Med (2002) 1.04
Association between type 2 diabetes mellitus and Helicobacter pylori infection. Turk J Gastroenterol (2007) 1.04
Effect of Helicobacter pylori infection on intragastric urea and ammonium concentrations in patients with chronic renal failure. J Clin Pathol (1993) 1.04
Endoscopic findings in end-stage renal disease. Endoscopy (2003) 1.04
Upper gastrointestinal findings in chronic renal failure. Scand J Gastroenterol (1987) 1.02
Assessment of the upper gastrointestinal tract in hemodialysis patients awaiting renal transplantation. Am J Gastroenterol (1983) 1.01
Delay in gastric emptying in patients with chronic renal failure. Scand J Gastroenterol (2004) 0.97
Helicobacter pylori antibodies in hemodialysis patients and renal transplant recipients. Clin Transplant (1999) 0.97
Usefulness of non-invasive tests for diagnosing Helicobacter pylori infection in patients undergoing dialysis for chronic renal failure. Helicobacter (2004) 0.97
Gastrin and gastric acid secretion in renal failure. Am J Surg (1981) 0.95
Antral Helicobacter pylori in patients with chronic renal failure. J Clin Pathol (1990) 0.95
Eradication and follow-up of Helicobacter pylori infection in hemodialysis patients. Nephron (1998) 0.92
Significantly lower prevalence of Helicobacter pylori in uremic patients than in patients with normal renal function. J Gastroenterol (1995) 0.92
Dyspepsia and gastroparesis in chronic renal failure: the role of Helicobacter pylori. Clin Nephrol (2002) 0.91
Prevalence of Helicobacter pylori in patients with chronic renal failure. Nephrol Dial Transplant (1993) 0.91
Impact of Helicobacter pylori infection on serum gastrin in haemodialysis patients. Nephrol Dial Transplant (1999) 0.90
Helicobacter pylori infection and chronic urticaria. J Am Acad Dermatol (1996) 0.90
Prevalence of gastroduodenal lesions in uremic patients undergoing dialysis and after renal transplantation. Gastrointest Endosc (1984) 0.90
Association of helicobacter pylori infection with nutritional status in hemodialysis patients. Transplant Proc (2004) 0.89
Gastroduodenal lesions and Helicobacter pylori infection in hemodialysis patients. Saudi Med J (2004) 0.88
Helicobacter pylori-specific IgG in chronic haemodialysis patients: relationship of hypergastrinaemia to positive serology. Nephrol Dial Transplant (1996) 0.88
Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients. Clin Exp Nephrol (2006) 0.87
Helicobacter pylori in patients receiving long-term dialysis. Am J Nephrol (2002) 0.87
Gastric juice ammonia and urea concentrations and their relation to gastric mucosa injury in patients maintained on chronic hemodialysis. Rocz Akad Med Bialymst (2005) 0.87
Prevalence of Helicobacter pylori antibodies in long-term dialysis patients. Nephrology (Carlton) (2004) 0.86
Esophagogastroduodenoscopy in chronic hemodialysis patients: 2-year clinical experience in a renal unit. Clin Nephrol (2002) 0.86
Prevalence of Helicobacter pylori in patients with end-stage renal failure and renal transplant recipients. Nephron (1991) 0.86
Helicobacter pylori infection in haemodialysis patients and renal transplant recipients. Nephrol Dial Transplant (1997) 0.86
Gastric Helicobacter and upper gastrointestinal symptoms in chronic renal failure. Ann Med (1991) 0.86
Diagnostic efficacy of (13)C-urea breath test for Helicobacter pylori infection in hemodialysis patients. Am J Kidney Dis (2000) 0.85
Significance of serum pepsinogens and their relationship to Helicobacter pylori infection and histological gastritis in dialysis patients. Nephrol Dial Transplant (1999) 0.85
Gastrointestinal hemorrhage in end stage renal disease patients. Int Surg (1990) 0.85
Seven-day triple therapy with omeprazole, amoxycillin and clarithromycin for Helicobacter pylori infection in haemodialysis patients. Scand J Gastroenterol (2002) 0.85
The gastrointestinal tract in uremic patients on long-term hemodialysis. Kidney Int Suppl (1985) 0.84
Helicobacter pylori in kidney allograft recipients: high prevalence of colonization and low incidence of active inflammatory lesions. Nephron (1997) 0.84
Frequency of Helicobacter pylori infection in uremic hemodialyzed patients with antral gastritis. Nephron (1996) 0.83
Epidemiology of Helicobacter pylori in chronic haemodialysis patients using the new RIBA H. pylori SIA. Nephrol Dial Transplant (1999) 0.82
Epidemiology of Helicobacter pylori in dialysis patients. Perit Dial Int (1995) 0.82
Prevalence of Helicobacter pylori antibodies in patients on chronic intermittent haemodialysis. Nephron (1991) 0.82
The effects of hemodialysis on duodenal and gastric mucosal changes in uremic patients. Clin Nephrol (1996) 0.81
Helicobacter pylori infection: a new cause of anorexia in peritoneal dialysis patients. Perit Dial Int (2001) 0.81
Campylobacter pylori: prevalence and significance in patients with chronic renal failure. Clin Nephrol (1989) 0.81
Upper gastrointestinal lesions in children on chronic haemodialysis. Nephrol Dial Transplant (2003) 0.81
Gastroduodenal lesions and Helicobacter pylori in children with end-stage renal disease. Pediatr Nephrol (2000) 0.81
Prevalence of Helicobacter pylori antibodies in CAPD patients. Nephron (1997) 0.81
Clinical characteristics and survival in end-stage renal disease patients with arteriosclerosis obliterans. Am J Nephrol (2002) 0.80
Upper gastrointestinal mucosal lesions in chronic renal failure. Indian J Gastroenterol (1991) 0.80
Helicobacter pylori antibodies in patients on chronic hemodialysis. Nephron (1996) 0.79
Decreased sensitivity of the ultrarapid urease test for diagnosing Helicobacter pylori in patients with chronic renal failure. Pathology (1999) 0.79
Seroprevalence of Helicobacter pylori in Chinese patients on continuous ambulatory peritoneal dialysis. Nephrology (Carlton) (2005) 0.79
Helicobacter pylori and uremic gastritis: a histopathologic study and a correlation with endoscopic and bacteriologic findings. Am J Nephrol (1997) 0.79
Dyspepsia in Turkish patients on continuous ambulatory peritoneal dialysis. Int Urol Nephrol (2008) 0.79
Low initial vitamin B12 levels in Helicobacter pylori--positive patients on chronic hemodialysis. Nephron Clin Pract (2004) 0.79
Traces of human migrations in Helicobacter pylori populations. Science (2003) 11.92
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology (2006) 3.68
C/EBPbeta is required for 'emergency' granulopoiesis. Nat Immunol (2006) 3.53
The peopling of the Pacific from a bacterial perspective. Science (2009) 3.14
Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol (2005) 2.87
Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet (2002) 2.71
Gain and loss of multiple genes during the evolution of Helicobacter pylori. PLoS Genet (2005) 2.61
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl (2005) 2.43
A report card to grade Helicobacter pylori therapy. Helicobacter (2007) 2.41
Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology (2002) 2.32
Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res (2008) 2.08
Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology (2005) 2.03
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer (2004) 2.03
Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter (2011) 2.00
Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res (2008) 1.91
Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice. J Hepatol (2002) 1.91
Perceptions and attitudes of clinical oncologists on complementary and alternative medicine: a nationwide survey in Japan. Cancer (2003) 1.82
Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg (2007) 1.82
Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res (2006) 1.79
A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. Am J Gastroenterol (2005) 1.79
Report of the 15th follow-up survey of primary liver cancer. Hepatol Res (2004) 1.78
Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res (2004) 1.60
Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice. J Gastroenterol Hepatol (2003) 1.58
Helicobacter pylori infection in mice: Role of outer membrane proteins in colonization and inflammation. Gastroenterology (2002) 1.58
Identification of long-term repopulating potential of human cord blood-derived CD34-flt3- severe combined immunodeficiency-repopulating cells by intra-bone marrow injection. Stem Cells (2007) 1.57
Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem Biophys Res Commun (2008) 1.56
Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery (2005) 1.54
Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol (2005) 1.53
c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest (2012) 1.53
Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond. Drugs (2008) 1.48
Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg (2002) 1.47
Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res (2002) 1.46
Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol (2005) 1.44
The relationship between Helicobacter pylori infection and Alzheimer's disease in Japan. J Neurol (2011) 1.44
Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg (2005) 1.44
Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori. Infect Genet Evol (2011) 1.44
Perioperative changes in carbonylhemoglobin and methemoglobin during abdominal surgery: alteration in endogenous generation of carbon monoxide. J Gastroenterol Hepatol (2002) 1.43
Analysis of Helicobacter pylori genotypes and correlation with clinical outcome in Turkey. J Clin Microbiol (2004) 1.42
Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer. Gastroenterology (2002) 1.39
Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J Clin Microbiol (2011) 1.37
Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol Biol Cell (2005) 1.37
Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg (2002) 1.35
Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter (2004) 1.35
Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology (2003) 1.34
Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am J Gastroenterol (2002) 1.34
A comprehensive sequence and disease correlation analyses for the C-terminal region of CagA protein of Helicobacter pylori. PLoS One (2009) 1.34
Antimicrobial activity of essential oils against Helicobacter pylori. Helicobacter (2003) 1.31
Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res (2003) 1.28
Correlation between Helicobacter pylori OipA protein expression and oipA gene switch status. J Clin Microbiol (2004) 1.27
Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem Biophys Res Commun (2005) 1.26
Report of the 16th follow-up survey of primary liver cancer. Hepatol Res (2005) 1.25
Population-based strategies for Helicobacter pylori-associated disease management: a Japanese perspective. Expert Rev Gastroenterol Hepatol (2010) 1.24
Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol (2004) 1.23
Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol (2003) 1.21
vacA genotypes of Helicobacter pylori in relation to cagA status and clinical outcomes in Iranian populations. Jpn J Infect Dis (2008) 1.20
Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3beta phosphorylation. Cell Microbiol (2008) 1.19
Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma. Mol Ther (2003) 1.18
vacA i-region subtyping. Gastroenterology (2008) 1.18
Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway. J Biol Chem (2008) 1.17
Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan. J Hepatobiliary Pancreat Surg (2002) 1.17
IL-17 is involved in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Helicobacter (2008) 1.17
Extremely high prevalence of Helicobacter pylori infection in Bhutan. World J Gastroenterol (2013) 1.16
Changes in Attitudes of Japanese Doctors toward Complementary and Alternative Medicine-Comparison of Surveys in 1999 and 2005 in Kyoto. Evid Based Complement Alternat Med (2011) 1.16
The significance of virulence factors in Helicobacter pylori. J Dig Dis (2013) 1.16
Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index. Am J Surg Pathol (2002) 1.16
Characterization of vacuolar transport of the endogenous alkaloid berberine in Coptis japonica. Plant Physiol (2005) 1.13
Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. J Clin Microbiol (2009) 1.13
Primary hepatic carcinoid tumor with metachronous lymph node metastasis after long-term follow up. J Gastroenterol Hepatol (2002) 1.13
Comparison of genotyping Helicobacter pylori directly from biopsy specimens and genotyping from bacterial cultures. J Clin Microbiol (2003) 1.13
Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci (2004) 1.13
Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors. J Virol (2004) 1.12
Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori. Infect Immun (2005) 1.12
Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin N Am (2003) 1.11
Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis. World J Gastroenterol (2008) 1.11
Pathogenesis of Helicobacter pylori Infection. Helicobacter (2005) 1.10
Management of adrenal metastasis from hepatocellular carcinoma. Surg Today (2002) 1.10
Role of IFN-gamma and tumor necrosis factor-alpha in herpes simplex virus type 1 infection. J Interferon Cytokine Res (2002) 1.09
The Helicobacter pylori urease B subunit binds to CD74 on gastric epithelial cells and induces NF-kappaB activation and interleukin-8 production. Infect Immun (2006) 1.09
Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils. Cancer Sci (2009) 1.09
Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice. Hepatology (2003) 1.08
Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome. Clin Gastroenterol Hepatol (2006) 1.08
African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. J Dig Dis (2009) 1.07
Disease association with two Helicobacter pylori duplicate outer membrane protein genes, homB and homA. Gut Pathog (2009) 1.07
Tumor thrombi in the portal vein system originating from gastrointestinal tract cancer. J Gastroenterol (2002) 1.06
The intact dupA cluster is a more reliable Helicobacter pylori virulence marker than dupA alone. Infect Immun (2011) 1.06
Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains. J Biol Chem (2007) 1.06
Distribution of Helicobacter pylori cagA, cagE, oipA and vacA in different major ethnic groups in Tehran, Iran. J Gastroenterol Hepatol (2009) 1.05
Immunological and Psychological Benefits of Aromatherapy Massage. Evid Based Complement Alternat Med (2005) 1.04
OipA plays a role in Helicobacter pylori-induced focal adhesion kinase activation and cytoskeletal re-organization. Cell Microbiol (2007) 1.03